_____________
Petitions and Communications
hist80950Pursuant to Senate Rule 17 (5), Senator Erpenbach withdrawn as a co-author of Senate Bill 167. _____________
Referrals and Receipt of Committee Reports Concerning Proposed Administrative Rules
The joint committee for review of Administrative Rules reported and recommended:
Relating to compounding pharmaceuticals.
Ayes: 10 – Senator Nass, Representative Ballweg, Senators LeMahieu, Stroebel, Larson and Wirch, Representatives Neylon, Ott, Hebl and Anderson.
Noes: 0 – None.
Relating to requests for written advice issued on behalf of the Ethics Commission.
Ayes: 10 – Senator Nass, Representative Ballweg, Senators LeMahieu, Stroebel, Larson and Wirch, Representatives Neylon, Ott, Hebl and Anderson.
Noes: 0 – None.
Relating to the operation of the prescription drug monitoring program.
hist80920No action taken on December 11, 2017. Relating to biennial registration.
hist80919No action taken on December 11, 2017. Relating to licensure requirements.
hist80918No action taken on December 11, 2017. STEPHEN NASS
Senate Chairperson
